Introduction {#Sec1}
============

Although cancer patients receive state-of-the-art medical care, they seldom have help coping with the detrimental effects of the illness on their quality of life (QOL) \[[@CR1]\]. Family caregivers provide complex care in the home with little support, which reduces caregivers' self-efficacy and increases their distress \[[@CR2]\]. Although interventions have been developed to support cancer patients and their family caregivers, they seldom move from efficacy testing to implementation in community settings where people can benefit from them \[[@CR3]\].

The FOCUS program is an evidence-based, psychoeducational intervention that improves patient and caregiver outcomes (e.g., emotional distress, QOL) as demonstrated in three randomized clinical trials (*[N]{.ul}* = 947 patient-caregiver pairs) \[[@CR4]--[@CR6]\]. We piloted implementation of FOCUS in one local Cancer Support Community (CSC) site with demonstrated effectiveness when implemented by agency social workers using a small group format \[[@CR7]\]. The purpose of this study was to examine program outcomes, feasibility, and satisfaction with implementation of FOCUS in two CSC sites outside our local community. We also examined costs of delivering the FOCUS program which has not been evaluated previously.

Study aims were as follows:To determine effects of the FOCUS program on patient-caregiver dyad's primary outcomes (emotional distress and quality of life) and secondary outcomes (benefits of illness, self-efficacy, dyadic communication) at CSC sites in Ohio and CaliforniaTo assess the feasibility of program implementation at these CSC sitesTo evaluate program satisfactionTo estimate costs of delivering FOCUS

Stress-coping theory \[[@CR8], [@CR9]\] is an important framework for understanding how patients and caregivers cope with cancer. According to the theory, a series of personal, social, and illness-related factors influence how patients' and caregivers' appraise the illness and cope with demands associated with it. Figure [1](#Fig1){ref-type="fig"} illustrates the stress-coping model as it applies to the FOCUS Program and the potential intervention effects examined in this study. The program provides patients and caregivers with information and support jointly (as unit of care), which helps increase positive appraisal of the illness (i.e., benefits of illness/caregiving), enhance coping resources (i.e., self-efficacy), improve quality of life, and reduce emotional distress.Fig. 1Theoretical framework: stress-coping model

Methods {#Sec2}
=======

Study design {#Sec3}
------------

The study was approved by the University of Michigan Institutional Review Board. A pre-post-intervention design (no control group) was used. Primary and secondary outcomes were completed at baseline (time 1) prior to the intervention and again 5 weeks later (time 2), following program completion. A control group was not used because three prior randomized controlled trials demonstrated the efficacy of the FOCUS program with significant findings across studies \[[@CR4]--[@CR6], [@CR10]\].

Sites {#Sec4}
-----

FOCUS was implemented at the CSC in Cincinnati, Ohio, and in Santa Monica, California, each serving approximately 1500 patients annually. The CSC is a large network of community agencies in the US that provides professional psychosocial care in a group format at no cost to cancer patients and their family caregivers. The racial mix at the Cincinnati CSC is principally Caucasian (81%) and African-American (11%) whereas the racial mix at the Santa Monica CSC site is Caucasian (69%), Asian (11%), and Hispanic (7%).

Participants {#Sec5}
------------

Patient eligibility criteria were (1) age 18 or older; (2) diagnosis of any cancer type including advanced cancer, currently in treatment or completed treatment in the past 18 months; (3) physically and mentally able to participate as determined by the intake licensed therapist; (4) able to read and speak English; and (5) have a family caregiver willing to participate in the program. Caregiver eligibility criteria were (1) age 18 or older, (2) physically and mentally able to participate, (3) able to speak and read English, (4) identified by the patient as the primary caregiver, and (5) willing to participate in the study. Family caregiver was defined as an individual who provided emotional and/or physical support to the patient, without pay. Caregivers were excluded if they were diagnosed with cancer in the previous year or were receiving active treatment for cancer so all dyads were managing the effects of cancer in the patient, not the caregiver. A sample size of 56 dyads was planned to provide 80% power \[[@CR11], [@CR12]\] to detect a medium effect size (*d* = .37) with alpha of .05 two tailed, based on the effects from our prior implementation study \[[@CR7]\].

The FOCUS intervention {#Sec6}
----------------------

FOCUS is a psychoeducational intervention delivered to patient-caregiver pairs (dyads) that addresses **F**amily involvement, **O**ptimistic attitude, **C**oping effectiveness, **U**ncertainty reduction, and **S**ymptom management (see Table [1](#Tab1){ref-type="table"}) \[[@CR13]\]. The program was delivered by a master's prepared facilitator (licensed social worker, family therapist) employed by each of the CSC sites, in a group format of three to four dyads (6--8 people), and was comprised of five weekly face-to-face sessions of 2 hours each. Eleven five-session FOCUS programs were delivered over 12 months.Table 1Outline of the FOCUS program content by weekFOCUSWeekFamily involvementOptimistic attitudeCoping effectivenessUncertainty reductionSymptom management**1**• Family composition and cancer history• Roles and involvement in plan of care• Impact of illness on family*Educational Materials*• *"Caregiving for Your Loved One with Cancer" Booklet*• Current outlook• Sources of hope• Current coping strategies• Informational needs• Communicating informational needs with health care providers• Symptoms of patient and caregiver• Clarify myths about treatment or disease• Communicating symptoms with health care providers• Strategies for managing common symptoms of patient and caregiver (pain, fatigue)*Education Materials*• "*Caring for the Cancer Patient at Home*"**2**• Current response to cancer• Importance of mutual support and team work• Family strengths• Current outlook• Importance and benefits of optimism• Strategies for a positive outlook*Educational Materials*• *Optimism magnet*• Current coping strategies• Active vs. passive coping strategies• Benefits of relaxation*Educational Materials*• *Guided imagery relaxation CD*• Informational needs• Strategies to obtain factual information• Normalize feelings of uncertainty• Symptoms and symptom management follow-up• New symptoms• Strategies for managing common symptoms patient and caregiver**3**• Review mutual support• Communication strategies within patient-caregiver dyad (e.g. pair) and with other family members• Current outlook• Ventilation of feelings and worries• Identification of activities with positive or meaningful focus*Educational Materials*• *"Fostering An Optimistic Outlook"*• Review active vs. passive coping strategies• Realistic stress management activities• Informational needs• Obtaining information from health care providers and other sources• Active participation with healthcare team• Normalize feelings of uncertainty• Caregiver emotional and physical symptoms• Importance of self-care for caregiver• Symptom management**4**• Current response to cancer• Review team approach• Support and unmet needs*Educational Materials*• *"Family Communication and Cancer"*• Daily use of optimism strategies• Review strategies from booklet• Stress management techniques (relaxation techniques, journal)• Healthy living strategies (nutrition, physical activity, rest, conserving energy)• Encourage asking questions• Strategies for day-to-day living with uncertainty*Educational Materials*• *"Five Wishes"*• Symptoms and symptom management• Sensitive symptoms (e.g. sexual dysfunction) and communicating these symptoms to health care providers• Encourage active reporting of symptoms and follow-up**5**• Family problems in response to illness and treatment (extended family and children)• Genetic risk of cancer for family members• Problem solving strategies• Review communication techniques• Identify gains*Educational Materials*• *"Helping Your Children Cope With Your Cancer"*• Realistic goal setting for future• Maintaining a positive outlook• Daily use of optimism strategies• Reinforce active coping and healthy living strategies• Accepting help from others• Community resources and referrals• Informational needs• Review how to obtain needed information• Typical emotional and physical reactions to cancer• Strategies for living with uncertainty• Strategies for future concerns (advanced directives and wills)• Review symptom management• Support symptom management• Encourage active reporting of symptoms and follow-upNote: These are general guidelines. The exact timing of the content for each week may vary according to the needs of each group

Implementation strategies {#Sec7}
-------------------------

Implementation was guided by the Translating Research into Practice Model in which implementation is promoted through communication among program developers and program facilitators \[[@CR14]--[@CR16]\]. Thus, an Implementation Training Manual and a FOCUS Intervention Protocol Manual were developed. The training manual was designed to educate CSC program directors and facilitators about the efficacy of FOCUS, program components, resources for implementation, and the research components (e.g., informed consent). The FOCUS Intervention Protocol Manual was designed for use by the facilitator to foster delivery and documentation of fidelity to the weekly FOCUS activities. A 1-day training program was held for CSC site program directors and facilitators (see Table [2](#Tab2){ref-type="table"}). Other implementation strategies included (1) providing sets of pre-packaged materials to implement each 5-week FOCUS program, (2) weekly conference calls with facilitators to provide guidance on issues that arose, and (3) teleconference attendance of the facilitators at monthly investigator team meetings.Table 2Outline of the training program for CSC sitesTopicPresenter/facilitatorTime allocationWelcome and introductionsM. Titler30 minImplementation of evidence-based programs: overviewM. Titler15 minFOCUS program• History, development and testing• Core components: F-O-C-U-S• Implementation in CSC• Project aims• Expectations• Timeline for this projectL. Northouse45 minPre-implementation-• Roles and responsibilities of ○ CSC program director, ○ Group facilitator• Interagency communication• Marketing materials• Recruitment and retentionB. Dockham60 minImplementation• Intake screening and eligibility• FOCUS Intervention Protocol Manual• Educational materials• Dyad binder for materials• FOCUS intervention fidelity---checklist• Participant commitment• Building groups and group dynamics• Overcoming potential barriers• Training video, case scenarios and discussionB. Dockham withL. NorthouseA. SchafenackerM. Visovatti135 minResearch component• Obtaining consent• Use of coding and tracking log• Questionnaires for patient and caregiver• Data collection procedures• Baseline and follow-up packets for patient and caregiver• Data for cost analysis• Data storage and security• Procedures for returning questionnaires and other data to UM• Potential adverse events and reporting• Monthly teleconference with investigative teamL. NorthouseM. VisovattiM. TitlerB. Dockham90 minFurther discussion and wrap-upAll30 min

Instruments {#Sec8}
-----------

### Primary outcomes {#Sec9}

Emotional distress was measured using the *Cancer Support Source Distress Scale (CSSDS)* developed by the Cancer Support Community \[[@CR17]\]. Reliability and validity have been demonstrated \[[@CR17]\]. Quality of life was measured using the *Functional Assessment of Cancer Treatment-General (FACT-G) QOL Scale* (version 4) \[[@CR18]\]. The FACT-G has demonstrated validity, and both the original and modified versions have demonstrated reliability in cancer patients and their caregivers \[[@CR5]--[@CR7]\] (see Table [3](#Tab3){ref-type="table"}).Table 3Primary and secondary outcome measuresInstrument nameDescriptionScoring and interpretationCancer Support Source Distress Scale \[[@CR17]\]Consists of 15 items to measure the extent of concern (0 = not at all to 5 = very seriously) about various emotions related to the cancer experienceScore of 0 to 60 is calculated by summing ratings across all items. Higher scores indicate greater emotional distressFACT-G (version 4) \[[@CR18]\]Consists of 27 items to measure overall QOL, and the domains for physical, social, emotional, and functional well-being in cancer patients (0 = not at all to 4 = very much). For caregivers, FACT-G was slightly modified using nearly identical items \[[@CR19]\]QOL score of 0--108 is calculated by summing item ratings across all domains. Domain scores are calculated by summing individual items within the domain. Higher scores indicate higher well-being (subscales) and QOLBenefits of Illness Scale \[[@CR20]\]Consists of 11 items to measure patients and caregivers perceived benefits (1 = not at all to 4 = a lot) arising from the cancer illnessScore of 1 to 4 is calculated by summing ratings on all items and dividing by 11. Higher scores indicate more perceived benefits of illnessLewis' Cancer Self-efficacy Scale \[[@CR21]\]Consists of 17 items to measure patients' and caregivers confidence to manage cancer (0 = not at all to 10 = very confident)Score of 0 to 170 is calculated by summing ratings across all items. Higher scores reflect higher self-efficacyLewis' Mutuality and Interpersonal Sensitivity Scale \[[@CR21]\]Consists of 23 items to measure dyadic communication about cancer (1 = never true to 5 = always true)Score of 1 to 5 is calculated by summing ratings across all items and dividing by 23. Higher scores indicate more perceived open communication between the patient and caregiver about cancer

### Secondary outcomes {#Sec10}

The *Benefits of Illness Scale* \[[@CR20]\] was used to measure patients' and caregivers' perceived benefits arising from the cancer illness (e.g., led me to be more accepting of things). Validity and reliability have been demonstrated \[[@CR20]\]. The *Lewis' Cancer Self-efficacy Scale* (CASE) was used to measure confidence to manage cancer \[[@CR21]\]. Validity and reliability have been demonstrated in multiple studies \[[@CR5], [@CR6], [@CR21]\]. The *Lewis' Mutuality and Interpersonal Sensitivity Scale (MIS)* was used to measure communication between the patient and caregiver about cancer \[[@CR21]\]. Validity and reliability have been demonstrated in multiple studies \[[@CR6], [@CR7], [@CR21]\] (see Table [3](#Tab3){ref-type="table"}). Demographic questions assessed participants' age, gender, marital status, race, education, income, and employment status. Medical-related questions assessed patients' type and stage of cancer, and whether they were currently receiving treatment.

### Feasibility {#Sec11}

Feasibility was measured by (1) enrollment and retention rates and (2) intervention fidelity. Data regarding fidelity to the FOCUS program was collected through the fidelity checklist in the FOCUS protocol manual, completed by the facilitator, for activities to be done during each of the five sessions. Activities to complete across the five sessions were 104 (session 1 = 25; session 2 = 17; session 3 = 18; session 4 = 19; session 5 = 25).

### Satisfaction {#Sec12}

Satisfaction was measured by the *FOCUS Satisfaction Instrument* \[[@CR7]\]. It includes seven items for rating satisfaction with components of the program (1 = not satisfied to 5 = very satisfied); ratings are summed and divided by seven to arrive at overall satisfaction scores. It includes open-ended questions regarding session lengths and FOCUS program length.

### Program costs {#Sec13}

Program costs were calculated by multiplying hourly time estimates and median hourly wages for healthcare social workers in California and Ohio according to the US Bureau of Labor Statistics, May 2015 (CA: \$32.53; OH: \$26.01). Costs were estimated for the average total cost to deliver one five-session FOCUS program at each site and across sites.

#### Time estimates {#FPar1}

Preparation and wrap-up time for each of the five sessions were estimated as 20 min based on our previous study \[[@CR7]\]. Facilitators at each of the two CSC sites logged the session time in minutes at the end of each session on the fidelity checklist. We summed across all 11 FOCUS Programs, (1) the logged session times and (2) the preparation and wrap-up times to arrive at the total time to deliver FOCUS; this was then divided by 11 (number of programs delivered) to arrive at the mean time to deliver a five-session FOCUS program. The mean total time across both sites to deliver FOCUS including preparation and wrap-up was 11.2 h (SD =0.3). We also accounted for estimated time for program oversight. These estimates per FOCUS program are based on our prior study as follows \[[@CR7]\]: marketing---1.5 h; recruiting and outreach---1 h; intake and screening for eligibility---7 h; and organization of education materials---1.5 h. These oversight estimates (11 h) were added to the mean time to deliver a five-session FOCUS program (11.2 h), as described above, resulting in an estimated 22.2 h to provide oversight and delivery of one five-session FOCUS program.

#### Cost estimates {#FPar2}

To calculate cost estimates, the time to provide oversight and delivery of FOCUS (22.2 h) was multiplied by the median hourly wage for each respective site, resulting in site specific cost estimates. The average cost across sites to provide oversight and deliver one FOCUS program was calculated by multiplying the site specific costs by the number of FOCUS programs delivered at each site. These values were then summed and divided by 11, the number of FOCUS programs delivered across sites.

### Data collection procedures {#Sec14}

Patient and caregiver versions of the baseline (time 1) questionnaires consisting of Cancer Support Source Distress Scale, FACT-G QOL Scale, Benefits of Illness Scale, Lewis' Cancer Self-Efficacy Scale, Lewis' Mutuality and Interpersonal Sensitivity Scale (see Table [3](#Tab3){ref-type="table"}), and demographic and medical-related questions were completed prior to beginning the FOCUS program. Questionnaires were mailed or given to participants during the intake visit and collected immediately prior to the first FOCUS program session. Patients and caregivers completed questionnaires independently. Follow-up questionnaires (time 2) included the major scales, noted above, and the Focus Satisfaction Instrument, and were administered immediately after the last FOCUS session.

### Data analysis {#Sec15}

For aim 1, repeated measures analysis of variance was used to determine if changes occurred in primary and secondary outcomes from time 1 to time 2 for patients and caregivers as dyads (i.e., pairs). Dyadic analysis was used because patients' and caregivers' responses to illness are interrelated \[[@CR22], [@CR23]\]. Time and role (patient vs. caregiver) were treated as within-subject variables to control for the interdependent nature of the data. Main effect by time was examined to determine the overall effectiveness of the FOCUS intervention on primary and secondary outcomes for patient-caregiver dyads as a unit. Time-by-role interactions were analyzed to determine if there was a differential effect of the intervention on patients' and caregivers' outcomes. Cancer stage was used as a control variable in the main effect analysis (effect of intervention on outcome) and interaction effect analysis (differential effect of intervention on patients' and caregivers' outcomes) for physical and functional well-being because significant associations (*p* \< 0.05) were found between cancer stage and these outcomes for patients (*F* = 3.46 for physical; *F* = 2.83 for functional). Intervention effect sizes were examined for specific variables based on conventional standards (small = 0.20; medium = 0.50; large = 0.80) \[[@CR11]\].

Descriptive statistics were used to examine enrollment and retention rates and intervention fidelity (aim 2). The *enrollment rate* was calculated by the number of dyads enrolled in the FOCUS program divided by the number eligible to participate. The *retention rate* was calculated by the number of dyads who completed the FOCUS program divided by the number who enrolled. For intervention fidelity, there were 104 total activities to complete across the five sessions per FOCUS program, and a total of 11 FOCUS programs were delivered. Fidelity for the FOCUS program was calculated by summing the number of activities documented as provided across all sessions for the 11 FOCUS programs delivered divided by total activities possible by programs (104 × 11). This resulted in a mean fidelity for the FOCUS program which had been delivered 11 times.

Descriptive statistics were used to examine patients' and caregivers' total satisfaction scores (aim 3) with follow-up exploratory analyses using paired *t* tests to examine differences in patients' and caregivers' scores. Calculation of estimated program costs is described above.

Results {#Sec16}
=======

Participant characteristics {#Sec17}
---------------------------

The final sample was 36 dyads (see Fig. [2](#Fig2){ref-type="fig"}). Patients' mean age was 60.8 and caregivers' was 55.9 (see Table [4](#Tab4){ref-type="table"}). The majority of participants were female (patients, 52.8; caregivers, 55.6), and most were married or partnered (\>85%). The sample was largely white, with a moderate income. Most were well educated with a college education or higher. Most patients had stage II or IV cancer and were currently in treatment (69.4%).Fig. 2FOCUS CSC consort diagram final *N* = 36 dyads Table 4Demographic and medical characteristics of sampleCharacteristicsPatients (*n* = 36)Caregivers (*n* = 36)MeanSDRangeMeanSDRangeAge60.814.218--8855.915.119--83*n*%*n*%GenderMale1747.21644.4Female1952.82055.6Marital statusMarried/partnered3288.93186.1Single38.3513.9Divorced12.8RaceWhite3288.92877.8Asian12.838.3Black or African-American12.812.8Latino or Hispanic12.812.8Other12.812.8Missing25.5EducationLess than high school25.6High school grad or GED12.812.8Some college, technical or vocational school616.7719.4College graduate719.41438.9Some graduate school38.312.8Graduate degree1747.21233.3Prefer not to share12.8IncomeLess than \$39,99938.312.8\$40,000--\$99,9991438.91438.9\$100,000 or above1644.41541.7Missing38.3513.9EmploymentFull time513.91747.2Part time513.925.6Not employed925.0513.9Retired1336.1925.0Disabled411.1Student12.8Missing25.6Type of cancerBreast616.7Pancreatic411.1Gynecologic411.1Prostate411.1Brain38.3Lung38.3Lymphoma38.3Multiple myeloma25.6Colorectal/GI25.6Kidney/adrenal25.6Nose/throat25.6Skin (non-melanoma)12.8Stage of cancerI616.7II822.2III616.7IV1336.1Unknown25.6Missing12.8Currently in treatmentYes2569.4No1027.8Missing12.8

Effectiveness of the FOCUS program intervention {#Sec18}
-----------------------------------------------

The FOCUS program was effective (see Table [5](#Tab5){ref-type="table"}). The intervention had significant positive effects on dyads' primary outcomes of total QOL (*p* = .014), emotional (*p* = .012) and functional (*p* = .049) well-being, and emotional distress (*p* = .002). The intervention did not have significant effects on physical and social well-being. The intervention had significant positive effects on the dyads' secondary outcomes of benefits of illness (*p* = .013) and self-efficacy (*p* = .001) but not on dyadic communication regarding cancer. Reliability of instruments in this study was high (see Table [5](#Tab5){ref-type="table"}).Table 5Effectiveness of the FOCUS program intervention (*N* = 36 dyads)Mean (SD)*p* valuesEffect sizes^b^PatientCaregiverMain effectInteraction effectPatientCaregiverDyadOutcomesReliabilities^a^Time 1Time 2Time 1Time 2Time\*Role by time\*\**ddd*Quality of life Total QOL.92; .8667.24(17.40)71.52(16.91)72.59(11.97)76.11(15.72)*.014*.8260.2490.2520.309 Physical.84; .7317.67(5.47)18.58(6.38)24.29(2.72)23.75(4.86).986.4120.1530.1370.030 Social.84; .7118.15(5.85)19.51(5.37)18.08(4.98)18.77(5.11).061.3920.2420.1360.214 Emotional.86; .8314.92(5.97)16.42(5.04)13.53(4.40)14.64(5.59)*.012*.6950.2720.2210.341 Functional.79; .8416.51(4.89)17.01(5.15)16.57(4.59)18.95(5.34)*.049*.5200.0100.4770.400Benefits of illness.88; .922.88(.65)2.97(.61)2.80(.65)2.98(.77)*.013*.7310.1430.2530.264Communication.96; .963.52(.91)3.62(.75)3.49(.80)3.64(.77).075.3210.1200.1910.186Emotional distress.89; .9022.61 (11.67)18.31(9.38)20.86(9.59)18.58(10.58)*.002*.2360.4060.2260.411Self-efficacy.96; .97113.97 (32.43)119.11(29.35)105.08(32.31)122.47(32.23)*.001*.0520.1660.5170.512^a^Reliabilities are the average across time points for patients and caregivers^b^Absolute value of effect size (Cohen's *d*) *d* = (mean1 − mean 2)/*s* where *s* = pooled standard deviation\*Significance (*p* value) of main effect by time: does the outcome change from time 1 to time 2 for the dyad; significant findings (*p* \< .05) are italicized\*\*Significance (*p* value) of interaction effect of role by time: does the amount of change from time 1 to time 2 differ for patients and caregivers; no significant findings (*p* \> .05)

Feasibility {#Sec19}
-----------

As displayed in Fig. [2](#Fig2){ref-type="fig"}, the enrollment rate was 71.4% and the retention rate was 90%. Intervention fidelity was 85%.

Satisfaction {#Sec20}
------------

Caregivers and patients reported high satisfaction, and scores did not differ significantly \[(patients: 4.4 (SD 0.6); caregivers: 4.5 (SD 0.5)\]. The majority of patients (86.1%) and caregivers (80.6%) reported the program helped them cope with cancer. Most reported that the program did not duplicate services provided at their treatment center (85.3% each). When asked about the length of each session (about right; shorter; longer), the majority of patients (86.1%) and caregivers (80.6%) noted the session lengths were about right. When asked about the number of group sessions (about right, fewer, more), 52.8% of the patients and 50% of the caregivers wanted more; 47.2% noted the number was about right. Over 90% of patients and caregivers noted they would recommend the program to others facing cancer.

Estimated program costs {#Sec21}
-----------------------

Due to differing geographic hourly wage rates, California estimated costs (\$722.17) were higher than Ohio (\$577.42). Average cost estimates for oversight and delivery of one five-session FOCUS program was \$669.45 or \$168.00 per dyad, assuming four dyads per group.

Discussion {#Sec22}
==========

Program effectiveness {#Sec23}
---------------------

The FOCUS program was effective in improving the primary outcomes of quality of life, emotional and functional well-being, and emotional distress. This is consistent with other couple-based group interventions for cancer patients and their partners \[[@CR24]\]. In qualitative statements, patients and caregivers reported that it was very helpful to have their partner or caregiver attend the group intervention with them. Both patients and caregivers were able to express feelings and learn from others, and this opportunity may have helped improve their QOL and emotional distress. FOCUS also was effective in improving perceived benefits of experiencing cancer (benefits of illness) and level of confidence in managing it (self-efficacy). Prior research with cancer patients and caregivers has demonstrated that group interventions facilitate positive reappraisal of the illness \[[@CR25]\] and can increase caregivers' preparedness and competence to provide care \[[@CR26]\]. The findings and effect sizes obtained for the domains of QOL, benefits of illness, and self-efficacy in this study are similar to those obtained in our prior randomized trials when FOCUS was delivered by a nurse to individual dyads at home \[[@CR4]--[@CR6], [@CR27]\] and in our previous implementation study \[[@CR7]\]. The magnitude of the intervention effects in this study are similar to small-medium effect sizes reported in three meta-analyses examining intervention effects with patients and caregivers across multiple studies \[[@CR3], [@CR28], [@CR29]\].

Participants' physical well-being, social well-being, and dyadic communication did not improve. The lack of improvement in physical well-being (e.g., nausea, pain) is not surprising because FOCUS is a psychoeducational intervention and improvements in physical well-being require tailored interventions that address the biological components of cancer. However, there was an improvement in functional well-being (e.g., ability to work; enjoy life). Perhaps, participants learned how to address physical challenges and related symptoms so that they could function in their daily lives. The lack of improvement in social well-being may be due to higher baseline social well-being scores with less room for improvement. Lack of improvement in dyadic communication is difficult to explain. FOCUS may have stimulated beginning communication about cancer that did not carry over into participants' daily lives. Additional work regarding how communication is conceptualized and measured as an outcome of FOCUS may be warranted in future studies (i.e., qualitative approach with participants).

Feasibility {#Sec24}
-----------

It is feasible to deliver FOCUS in a group format in CSC sites. Enrollment rates were good (71.4%) and higher than those reported in other studies using group interventions with patient-caregiver dyads (10.4%) \[[@CR24]\] or family caregivers (25--31%) \[[@CR30], [@CR31]\]. Perhaps this is because agency staff recruited participants and delivered the intervention. Retention rates (90%) were high most likely because of perceived benefits from the group and its dyadic approach.

FOCUS was delivered with high intervention fidelity (85%) and was similar to a couple-focused group intervention with breast cancer patients (88%) \[[@CR24]\]. The implementation strategies were important for providing initial and ongoing support to the group facilitators and helped maintain high intervention fidelity.

Satisfaction {#Sec25}
------------

Participants were highly satisfied with the FOCUS program and the overwhelming majority would recommend the program to others. About half of the participants wanted more sessions, raising the issue of optimal intervention dose. In our prior implementation study, using a six-session group intervention, \>40% of the participants also reported they would have liked more sessions \[[@CR7]\]. One challenge in planning an intervention is balance between feasibility (i.e., enrollment, retention) and outcomes (i.e., program effectiveness). Manne et al. \[[@CR24]\] found a low enrollment rate (10.4%) among cancer patients who were approached for an 8-week group intervention, with 15.7% expressing worry about the program length. Bultz et al. \[[@CR30]\] found low enrollment (31%) for a 6-week group intervention for partners, with 29% stating time was an issue. Determining optimal intervention dose needs further exploration.

Program cost {#Sec26}
------------

This study provided the first cost estimate of delivering the five-session FOCUS program; about \$168.00 per dyad. Badger et al. \[[@CR32]\] estimated costs of their 8-week dyadic telephone intervention as \$164.68 per dyad but omitted oversight and preparation costs included in our estimates. Given the skyrocketing healthcare costs in the US, FOCUS is highly economical to address critical issues of those living with cancer.

Limitations {#Sec27}
-----------

One limitation is enrollment of 36 rather than 56 dyads as planned. Despite this limitation, the dyadic effects for many variables were \>0.30, and we were able to demonstrate the effectiveness of the FOCUS program. Performing cost-effective analyses was not a study aim and requires use of a control group which deprives patients and caregivers from an intervention that has demonstrated efficacy and effectiveness. We did, however, provide a cost estimate for delivery of FOCUS in CSCs.

Conclusions {#Sec28}
===========

FOCUS delivered in a group, dyadic format is an economically feasible intervention that decreases emotional distress and improves quality of life, perceived benefits from experiencing cancer, and confidence in managing it. It is time that programs like FOCUS receive national public policy attention to effect payment structures for delivery to cancer patients and their caregivers.
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